IMMUNE-MEDIATED CHOLESTASIS

This adverse event was reported 37 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED CHOLESTASIS:

# Drug Count
0 NIVOLUMAB 11
1 CARBOPLATIN 7
2 PACLITAXEL 6
3 IPILIMUMAB 5
4 OMEPRAZOLE 3
5 OMEPRAZOLE MAGNESIUM 3
6 AMLODIPINE 2
7 CYCLOPHOSPHAMIDE 2
8 CYCLOPHOSPHAMIDE FOR INJECTION 2
9 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 2
See all common drugs associated with IMMUNE-MEDIATED CHOLESTASIS

IMMUNE-MEDIATED CHOLESTASIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIVOLUMAB AND RELATLIMAB-RMBW 1 0.0019
1 FOSNETUPITANT AND PALONOSETRON 2 0.0017
2 NETUPITANT AND PALONOSETRON 2 0.0017
3 CEMIPLIMAB-RWLC 1 0.0005
4 PYRIDOXINE HYDROCHLORIDE 1 0.0004
5 ENFORTUMAB VEDOTIN 1 0.0001
6 IPILIMUMAB 5 0.0001
7 NIVOLUMAB 11 0.0001
8 PAROXETINE HYDROCHLORIDE HEMIHYDRATE 2 0.0001
9 PACLITAXEL 6 0.0001
See all drugs enriched for association with IMMUNE-MEDIATED CHOLESTASIS